Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,557,000 | 824,900 | 883,900 | 1,232,900 | 712,900 |
| Depreciation Amortization | 1,086,800 | 577,200 | 552,100 | 533,200 | 500,800 |
| Income taxes - deferred | -47,000 | 29,200 | 22,200 | -525,800 | 54,700 |
| Accounts receivable | -955,900 | -123,100 | -30,800 | -9,200 | -89,600 |
| Accounts payable and accrued liabilities | -5,300 | -12,800 | 43,300 | 172,300 | -8,700 |
| Other Working Capital | -856,900 | -294,400 | -70,300 | 148,100 | -172,900 |
| Other Operating Activity | 1,356,600 | 443,700 | -95,000 | -53,400 | 199,900 |
| Operating Cash Flow | $2,135,300 | $1,444,700 | $1,305,400 | $1,498,100 | $1,197,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -40,100 | -27,500 | -22,300 | -36,200 | 13,500 |
| PPE Investments | -339,600 | -392,500 | -329,700 | -307,400 | -248,100 |
| Net Acquisitions | -267,600 | -874,300 | 540,400 | -1,882,600 | -548,600 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -12,500 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -2,500 | 0 |
| Other Investing Activity | 4,100 | 11,200 | 18,300 | -2,500 | 0 |
| Investing Cash Flow | $-643,200 | $-1,283,100 | $206,700 | $-2,228,700 | $-795,700 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 151,700 | 2,395,000 | 467,200 | 3,342,200 | 139,500 |
| Debt Repayment | -563,900 | -2,184,900 | -1,162,200 | -2,385,300 | -792,900 |
| Common Stock Issued | 55,900 | 64,700 | 69,100 | 73,600 | 70,600 |
| Common Stock Repurchased | -100,000 | -450,000 | -700,000 | -338,100 | -43,900 |
| Other Financing Activity | -61,100 | -77,500 | -64,000 | -99,200 | -44,300 |
| Financing Cash Flow | $-517,400 | $-252,700 | $-1,389,900 | $593,200 | $-671,000 |
| Exchange Rate Effect | 8,600 | 1,800 | -12,000 | 20,500 | -13,200 |
| Beginning Cash Position | 337,500 | 426,800 | 316,600 | 433,600 | 716,400 |
| End Cash Position | 1,320,800 | 337,500 | 426,800 | 316,600 | 433,600 |
| Net Cash Flow | $983,300 | $-89,300 | $110,200 | $-117,000 | $-282,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,135,300 | 1,444,700 | 1,305,400 | 1,498,100 | 1,197,100 |
| Capital Expenditure | -381,700 | -400,200 | -379,800 | -312,900 | -278,900 |
| Free Cash Flow | 1,753,600 | 1,044,500 | 925,600 | 1,185,200 | 918,200 |